COVID-19 ONE YEAR LATER, Part II: Testing and Vaccines
In the second part of VIGILINT’s two-part series COVID-19 1 Year Later, VIGILINT Ops Analyst and blogger Colin Schilly dives into the two critical hallmarks of the pandemic. Testing and vaccines. The development and rollout of several effective vaccines in under a year offer great hope for the pandemic’s end. Sadly, that day may still… Read more about COVID-19 ONE YEAR LATER, Part II: Testing and Vaccines
COVID-19 ONE YEAR LATER, Part I: The Best and Worst Handlings of the COVID-19 Crisis
On January 10, 2020, VIGILINT first reported a new strain of a coronavirus connected to a cluster of pneumonia cases linked to Wuhan, China. No one could have predicted the year that would follow. As of publishing, worldwide cases have reached 104 million with 2.27 million deaths. VIGILINT looks back at the critical events that… Read more about COVID-19 ONE YEAR LATER, Part I: The Best and Worst Handlings of the COVID-19 Crisis
COVID-19 Transmission: Surfaces
There is some risk of COVID-19 transmission from surfaces, but the primary disease transfer mode is airborne transmission. Several studies have analyzed the detection of COVID-19 on various surfaces. One such study, published by the New England Journal of Medicine in March 2020, largely shaped the discussion around SARS-COV-2 (the virus causing COVID-19 disease) transmissions… Read more about COVID-19 Transmission: Surfaces
COVID-19 Update: Vaccine Distribution
The Trump administration is reversing its COVID-19 vaccination strategy by authorizing the release of Pfizer-BioNtech and Moderna’s federally stockpiled vaccines. The previous policy withheld half the purchased doses to ensure the supply necessary for second doses, and states could only receive vaccines based on their adult population size. The new distribution strategy unveiled yesterday is intended… Read more about COVID-19 Update: Vaccine Distribution
VIGILINT Travel Notice: COVID-19 Testing for International Flights to the United States
COVID-19 TESTING FOR INTERNATIONAL FLIGHTS TO THE UNITED STATES 14 January 2021
COVID-19 Update: On the Single Deadliest Day of the Pandemic – LA County is Hardest Hit
The Situation in Los Angeles Yesterday was the single deadliest day of the pandemic with 4,000 deaths, and nowhere is harder hit than Los Angeles County. Cases have spiked drastically since December, with 809,052 cases and 10,739 deaths. Deaths were occurring every 8 minutes yesterday. The California Department of Health rates LA county as Tier 1:… Read more about COVID-19 Update: On the Single Deadliest Day of the Pandemic – LA County is Hardest Hit
COVID-19 Update: Mutated Strain Found in Minks
New SARS-CoV-2 Strain Found in Northern Europe’s Mink Population On November 5, 2020, Denmark reported 12 human cases of COVID-19 caused by a mutated SARS-CoV-2 strain carried by minks. Minks are a semi-aquatic mammal closely related to the weasel, otter, and ferret. Six other countries have reported outbreaks at mink farms including the Netherlands, Spain,… Read more about COVID-19 Update: Mutated Strain Found in Minks
COVID-19 Update: Convalescent Plasma
On Sunday, August 23, the US Federal Food and Drug Administration (FDA) announced an Emergency Use Authorization (EUA) for convalescent plasma as a treatment for hospitalized COVID-19 patients citing “known and potential benefits of the product outweigh the known and potential risks of the product.” The EUA would effectively enable physicians to treat COVID-19 patients… Read more about COVID-19 Update: Convalescent Plasma
COVID-19 Update: The Race for a Vaccine
Vaccine development for COVID-19 is topic number one, and our collective hope for going back to “normal” dangle on that needle. The global race to market includes pharma’s heavy hitters like Pfizer, Johnson & Johnson, AstraZeneca, and Moderna, a Cambridge, Massachusetts-based company that displayed hopeful results in Phase-1 trials and just this week received another… Read more about COVID-19 Update: The Race for a Vaccine
